EcoDrugPlus

Potassium Voltage-Gated Channel Subfamily Q Member 2

Ensembl ID : ENSFHEG00000006480
Gene Symbol: KCNQ2
3 Cross references
184 Possible Orthologues:

Potassium Voltage-Gated Channel Subfamily Q Member 3

Ensembl ID : ENSFHEG00000008303
Gene Symbol: KCNQ3
3 Cross references
193 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSFHEG00000012023
Gene Symbol: PSENEN
3 Cross references
185 Possible Orthologues:

Presenilin-1-Like

Ensembl ID : ENSFHEG00000010404
Gene Symbol: LOC105939576
3 Cross references
202 Possible Orthologues:

Primary Amine Oxidase, Liver Isozyme-Like

Ensembl ID : ENSFHEG00000022379
Gene Symbol: LOC105922131
2 Cross references
402 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSFHEG00000017198
Gene Symbol: LOC105935397
3 Cross references
250 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSFHEG00000007464
Gene Symbol: LOC105925946
3 Cross references
257 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSFHEG00000021418
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSFHEG00000002726
Gene Symbol: PTGDR2
4 Cross references
134 Possible Orthologues:

Prostaglandin D2 Receptor 2-Like

Ensembl ID : ENSFHEG00000013920
Gene Symbol: LOC105931509
2 Cross references
145 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSFHEG00000003760
Gene Symbol: PTGER3
3 Cross references
196 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) A

Ensembl ID : ENSFHEG00000019077
Gene Symbol: PTGER4A
1 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).